217 related articles for article (PubMed ID: 31969492)
1. SENP1 is a crucial promotor for hepatocellular carcinoma through deSUMOylation of UBE2T.
Tao Y; Li R; Shen C; Li J; Zhang Q; Ma Z; Wang F; Wang Z
Aging (Albany NY); 2020 Jan; 12(2):1563-1576. PubMed ID: 31969492
[TBL] [Abstract][Full Text] [Related]
2. UBE2T-regulated H2AX monoubiquitination induces hepatocellular carcinoma radioresistance by facilitating CHK1 activation.
Sun J; Zhu Z; Li W; Shen M; Cao C; Sun Q; Guo Z; Liu L; Wu D
J Exp Clin Cancer Res; 2020 Oct; 39(1):222. PubMed ID: 33087136
[TBL] [Abstract][Full Text] [Related]
3. LncRNA FRMD6-AS1 promotes hepatocellular carcinoma cell migration and stemness by regulating SENP1/HIF-1α axis.
Sun W; Lei X; Lu Q; Wu Q; Ma Q; Huang D; Zhang Y
Pathol Res Pract; 2023 Mar; 243():154377. PubMed ID: 36827886
[TBL] [Abstract][Full Text] [Related]
4. Ubiquitin-conjugating enzyme E2T knockdown suppresses hepatocellular tumorigenesis
Guo J; Wang M; Wang JP; Wu CX
World J Gastroenterol; 2019 Nov; 25(43):6386-6403. PubMed ID: 31798276
[TBL] [Abstract][Full Text] [Related]
5. UBE2T promotes hepatocellular carcinoma cell growth via ubiquitination of p53.
Liu LP; Yang M; Peng QZ; Li MY; Zhang YS; Guo YH; Chen Y; Bao SY
Biochem Biophys Res Commun; 2017 Nov; 493(1):20-27. PubMed ID: 28935368
[TBL] [Abstract][Full Text] [Related]
6. UBE2T promotes nasopharyngeal carcinoma cell proliferation, invasion, and metastasis by activating the AKT/GSK3β/β-catenin pathway.
Hu W; Xiao L; Cao C; Hua S; Wu D
Oncotarget; 2016 Mar; 7(12):15161-72. PubMed ID: 26943030
[TBL] [Abstract][Full Text] [Related]
7. SUMOylation of annexin A6 retards cell migration and tumor growth by suppressing RHOU/AKT1-involved EMT in hepatocellular carcinoma.
Yang Y; Huang L; Zhang N; Deng YN; Cao X; Liang Y; Hou H; Luo Y; Yang Y; Li Q; Liang S
Cell Commun Signal; 2024 Apr; 22(1):206. PubMed ID: 38566133
[TBL] [Abstract][Full Text] [Related]
8. UBE2T-mediated Akt ubiquitination and Akt/β-catenin activation promotes hepatocellular carcinoma development by increasing pyrimidine metabolism.
Zhu Z; Cao C; Zhang D; Zhang Z; Liu L; Wu D; Sun J
Cell Death Dis; 2022 Feb; 13(2):154. PubMed ID: 35169125
[TBL] [Abstract][Full Text] [Related]
9. SENP1-Mediated deSUMOylation Regulates the Tumor Remodeling of Glioma Stem Cells Under Hypoxic Stress.
Wen P; Li H; Liu L; Liu X; Xu Z; Dong J
Technol Cancer Res Treat; 2024; 23():15330338241257490. PubMed ID: 38803001
[No Abstract] [Full Text] [Related]
10. SENP1 promotes hypoxia-induced cancer stemness by HIF-1α deSUMOylation and SENP1/HIF-1α positive feedback loop.
Cui CP; Wong CC; Kai AK; Ho DW; Lau EY; Tsui YM; Chan LK; Cheung TT; Chok KS; Chan ACY; Lo RC; Lee JM; Lee TK; Ng IOL
Gut; 2017 Dec; 66(12):2149-2159. PubMed ID: 28258134
[TBL] [Abstract][Full Text] [Related]
11. METTL3-mediated m
Li B; Xiong X; Xu J; Peng D; Nie G; Wen N; Wang Y; Lu J
Oncogene; 2024 Mar; 43(14):1050-1062. PubMed ID: 38374407
[TBL] [Abstract][Full Text] [Related]
12. SENP1 regulates hepatocyte growth factor-induced migration and epithelial-mesenchymal transition of hepatocellular carcinoma.
Zhang W; Sun H; Shi X; Wang H; Cui C; Xiao F; Wu C; Guo X; Wang L
Tumour Biol; 2016 Jun; 37(6):7741-8. PubMed ID: 26695141
[TBL] [Abstract][Full Text] [Related]
13. SUMO-Specific Cysteine Protease 1 Promotes Epithelial Mesenchymal Transition of Prostate Cancer Cells via Regulating SMAD4 deSUMOylation.
Zhang X; Wang H; Wang H; Xiao F; Seth P; Xu W; Jia Q; Wu C; Yang Y; Wang L
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28417919
[TBL] [Abstract][Full Text] [Related]
14. The interplay of UBE2T and Mule in regulating Wnt/β-catenin activation to promote hepatocellular carcinoma progression.
Ho NPY; Leung CON; Wong TL; Lau EYT; Lei MML; Mok EHK; Leung HW; Tong M; Ng IOL; Yun JP; Ma S; Lee TKW
Cell Death Dis; 2021 Feb; 12(2):148. PubMed ID: 33542213
[TBL] [Abstract][Full Text] [Related]
15. SENP1 promotes triple-negative breast cancer invasion and metastasis via enhancing CSN5 transcription mediated by GATA1 deSUMOylation.
Gao Y; Wang R; Liu J; Zhao K; Qian X; He X; Liu H
Int J Biol Sci; 2022; 18(5):2186-2201. PubMed ID: 35342335
[TBL] [Abstract][Full Text] [Related]
16. UBE2T promotes β-catenin nuclear translocation in hepatocellular carcinoma through MAPK/ERK-dependent activation.
Lioulia E; Mokos P; Panteris E; Dafou D
Mol Oncol; 2022 Apr; 16(8):1694-1713. PubMed ID: 34614271
[TBL] [Abstract][Full Text] [Related]
17. SENP1 is required for the growth, migration, and survival of human adipose-derived stem cells.
Wu Y; Yu B; Wang M
Adipocyte; 2021 Dec; 10(1):38-47. PubMed ID: 33371766
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of ubiquitin-conjugating enzyme E2T (UBE2T) predicts poor prognosis and promotes hepatocellular carcinoma progression.
Ren X; Li A; Ying E; Fang J; Li M; Yu J
Bioengineered; 2021 Dec; 12(1):1530-1542. PubMed ID: 33934686
[TBL] [Abstract][Full Text] [Related]
19. N6-methyladenosine-modified SENP1, identified by IGF2BP3, is a novel molecular marker in acute myeloid leukemia and aggravates progression by activating AKT signal via de-SUMOylating HDAC2.
Wen D; Xiao H; Gao Y; Zeng H; Deng J
Mol Cancer; 2024 May; 23(1):116. PubMed ID: 38822351
[TBL] [Abstract][Full Text] [Related]
20. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q
BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
